Clinical Trial Update: Safety and Efficacy of Dexmedetomidine in Controlling Hemodynamics During Resection of Active Thyroid Secreting Tumors [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update reporting safety and efficacy data for using dexmedetomidine to control hemodynamics during resection of active thyroid secreting tumors, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thyroid Neoplasms

Drugs mentioned

• Dexmedetomidine (Precedex) (dexmedetomidine)

Snippet

Sponsor: South Egypt Cancer Institute | Conditions: Thyroid Neoplasms | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING